John Landis Net Worth & Insider Trades

John Landis Eyepoint Pharmaceuticals, Inc

As of February 13, 2023

What is John Landis's Net Worth?

The current estimated net worth of Eyepoint Pharmaceuticals, Inc's John Landis is estimated to be about $171.4K . John Landis owns about 40,000 units of Eyepoint Pharmaceuticals, Inc common stock. In the last 5 years at Eyepoint Pharmaceuticals, Inc, John Landis has sold an estimated value of $0 worth.

What is John Landis's Past Insider Trading?

John Landis's largest purchase order was 40,000 units , worth over $69.6K on May 15, 2019. In total, John Landis has made about 8 transactions over 5 years of their time at Eyepoint Pharmaceuticals, Inc. John Landis usually trades in February, March and June, with the busiest year in 2021 and 2019.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is John Landis's' Mailing Address?

  • Mailing address is 1700 Kent Avenue West Lafayette IN 46906 IN

Eyepoint Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Nancy Lurker 2020 $581,957 - $482,460 $563,216 $454,508 $15,660 $2,097,801
Nancy Lurker 2019 $577,037 - $650,207 $693,165 $144,034 $15,340 $2,079,783
George Elston 2020 $440,000 - - $83,104 $236,940 $15,660 $775,704
George Elston 2019 $58,385 $20,000 - $635,555 - $2,068 $716,008
Dario Paggiarino 2020 $436,156 - $158,864 $185,417 $242,371 $15,660 $1,038,468
Dario Paggiarino 2019 $420,862 - - $275,775 $105,188 $15,340 $817,165
Scott Jones 2020 $376,250 - $158,864 $185,417 $212,135 $15,660 $948,326
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1314102/000156459021022639/eypt-def14a_20210622.htm

What are Eyepoint Pharmaceuticals, Inc's Past Insider Trades?

Eyepoint Pharmaceuticals, Inc's most recent insider trade came on March 15, 2022 by Craig Michael Pine who bought 1,000 units worth $12.21K . In the last 4 years, insiders at Eyepoint Pharmaceuticals, Inc have sold an estimated value of $518.41K and bought an estimated value of $22.04M worth of shares. Insider trading is most common in June, with the busiest year in 2019. The most active traders at the company are Nancy Lurker, CEO,  Dario Paggiarino, Chief Medical Officer,  and Jay Duker, President and COO .

EyePoint Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...